Burning Rock Biotech (BNR) Current Assets (2019 - 2026)

Burning Rock Biotech's Current Assets history runs 8 years deep, the most recent figure standing at $101.6 million for Q1 2026.

• In Q1 2026, Current Assets fell 3.16% year-over-year to $101.6 million; the TTM figure through Mar 2026 stood at $101.6 million (down 3.16% YoY), while the FY2025 annual figure was $105.6 million, down 0.73% from the prior year.
• Current Assets for Q1 2026 stood at $101.6 million, down from $104.1 million in the prior quarter.
• The five-year high for Current Assets was $265.9 million in Q1 2022, with the low at $101.6 million in Q1 2026.
• The 5-year median for Current Assets is $116.5 million (2024), against an average of $140.5 million.
• The sharpest annual moves came in 2022 and 2026: Current Assets plunged 38.44% in 2022, then declined 3.16% in 2026.
• Burning Rock Biotech's Current Assets stood at $177.0 million in 2022, then slumped by 30.62% to $122.8 million in 2023, then dropped by 11.95% to $108.1 million in 2024, then fell by 3.68% to $104.1 million in 2025, then slipped by 2.41% to $101.6 million in 2026.
• Business Quant data shows BNR's Current Assets at $101.6 million in Q1 2026, $104.1 million in Q4 2025, and $103.9 million in Q3 2025.